Jornadas sobre el VPH 2017

Infectious Diseases
On-site
Spanish
Recinte Modernista de Sant Pau, Barcelona

Status

Activity finished

Price

Free

Do you want to know the next activities activities on HVP?

Join our newsletter list to be updated on upcoming activities.

Information

Infection with human immunodeficiency virus (HIV) places individuals at greatly increased risk of developing anal squamous cell cancer associated with persistent infection with high-risk (HR) human papillomavirus (HPV).

Screening and treatment paradigms are both well established for the uterine cervix and female genital tract, but this is not the case for either the anus or oropharynx.

Worldwide, there are very few clinicians with expertise in HRA, analogous to cervical colposcopy, the technique used to both diagnose and facilitate ablation of dysplastic tissue. The city of Barcelona has a high concentration of these skilled HRA clinicians, in addition to world class HPV epidemiology researchers.

With increasing rates of both these cancers, this program offers a unique opportunity for professionals to learn in depth about anal and oropharyngeal HPV, the latest cutting-edge research in HPV science, oncology and vaccinology, combined with a practical training in anal cytology, clinical assessment of the anus and perianus, condyloma treatment techniques, digital anorectal examination, HRA, and minimally invasive ablation techniques for HSIL.

Program:

Coordinators

Adrià Curran

Assistant physician

Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Adrià Curran

Assistant physician

Adrià Curran is a staff physician of the Infectious Diseases Department of the Vall d’Hebron University Hospital and is the coordinator of the Anal Dysplasia Screening Unit of Vall d’Hebron University Hospital. He has carried out specific training on HPV anal dysplasia in HIV patients at the University of San Francisco (CA, USA) with Prof. Joel Palefsky. He is a member of the International Anal Neoplasia Society. He participates as a researcher in multiple international clinical trials and has published more than 100 articles in national and international journals and book chapters on various aspects of HIV infection, HPV and its treatment.

Accreditation

The theoretical and practical sessions of the “Conference on HPV (Human Papiloma virus) 2018” have been accredited by the Comissió de Formació Continuada del Sistema Nacional de Salut and the Consell Català de la Formació Continuada de les Professions Sanitàries (CCFCPS) with 2,4 credits and registered under the number 09/020130-MD.
The plenary session of the “Jornades sobre el VPH (Virus del Papiloma Humano) 2018” has been accredited by the Comissió de Formació Continuada del Sistema Nacional de Salut and the Consell Català de la Formació Continuada dels Professions Sanitàries (CCFCPS) with 0,9 credits and registered with the number 09/020135-MD.